Vireo Growth (VREOF) Operating Expenses (2020 - 2026)
Vireo Growth (VREOF) posted Operating Expenses of $50.3 million for Q1 2026, down 14.31% sequentially from $58.7 million in Q4 2025, and up 383.65% YoY from $10.4 million in Q1 2025.
Vireo Growth (VREOF) Operating Expenses (2020 - 2026) Analysis & Trends
Vireo Growth has reported Operating Expenses for 7 years, with the latest figure at $50.3 million in Q1 2026.
- Quarterly Operating Expenses rose 383.65% year-over-year to $50.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $168.0 million (up 318.73% YoY) and the FY2025 annual result came in at $128.1 million, up 244.4% from the prior year.
- Operating Expenses declined to $50.3 million in Q1 2026 per VREOF's latest filing, from $58.7 million in the prior quarter.
- Over five years, Operating Expenses peaked at $58.7 million in Q4 2025 and troughed at $6.7 million in Q4 2023.
- A 5-year average of $16.9 million and a median of $10.1 million in 2022 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2024 and 2026: Operating Expenses decreased 25.23% in 2024, then surged 383.65% in 2026.
- Over 5 years, Operating Expenses stood at $7.8 million in 2022, then slipped by 14.59% to $6.7 million in 2023, then soared by 102.2% to $13.5 million in 2024, then jumped by 335.0% to $58.7 million in 2025, then retreated by 14.31% to $50.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $50.3 million, $58.7 million, and $36.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Vireo Growth | 493.25 Mn | 350.95 Mn | 95.30 Mn | 101.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.30 Mn |
| Dec 31, 2025 | 58.70 Mn |
| Sep 30, 2025 | 36.57 Mn |
| Jun 30, 2025 | 22.44 Mn |
| Mar 31, 2025 | 10.40 Mn |
| Dec 31, 2024 | 13.49 Mn |
| Sep 30, 2024 | 8.47 Mn |
| Jun 30, 2024 | 7.76 Mn |
| Mar 31, 2024 | 7.48 Mn |
| Dec 31, 2023 | 6.67 Mn |
| Sep 30, 2023 | 7.33 Mn |
| Jun 30, 2023 | 10.37 Mn |
| Mar 31, 2023 | 9.15 Mn |
| Dec 31, 2022 | 7.81 Mn |
| Sep 30, 2022 | 9.73 Mn |
| Jun 30, 2022 | 10.06 Mn |
| Mar 31, 2022 | 10.25 Mn |
| Dec 31, 2021 | 10.41 Mn |
| Sep 30, 2021 | 9.25 Mn |
| Jun 30, 2021 | 10.16 Mn |